Grants & Awards :

Patents :

Presentations & Poster Sessions :

1. Oct, 1992 The 5th congress on Pediatric diseases: The temporal lobe epilepsy in children – as a speaker; Tehran university of medical science-Iran 2. 1992 The seminar of cerebral palsy: Report of 30 cases of CP – as a speaker; Tehran university of Rehabilitation sciences-Iran 3. Apr, 1993 The 5th congress on internal medicine: Brainstem tuberculoma - as a speaker ;Isfahan university of medical science-Iran 4. Jun, 1993 The seminar of poliomyelitis: clinical manifestation of poliomyelitis - as a speaker; Isfahan University of medical science-Iran 5. Oct , 1995 The 8th congress of pediatric diseases: Tourette syndrome; report of 20 cases - as a speaker; Tehran university of medical science-Iran 6. Sep, 1996 The 9th international congress of neurology and clinical electrophysiology: The efficacies of toxin botulinum type A (Dysport) in spastic hemiplegia due to CVA – as a speaker; Shaheed Beheshti University of medical sciences-Iran 7. Oct 1996 The 9th congress on Pediatric diseases: Lennox Gastaut syndrome; report of 30 cases – as a speaker; Tehran university of medical Science-Iran 8. Sep, 1997 The first Mediterranean neurology conference and 5th Mediterranean epilepsy conference: The outcome of absence epilepsy: analysis of 93 patients, abdominal epilepsy in adults –as poster presentation; Montpellier- France 9. Oct, 1997 The 10th congress on Pediatric diseases: The survey of 112 epileptic children in Isfahan– as poster presentation; Tehran university of medical Science-Iran 10. Oct, 1998 The first congress of psychopharmacology: treatment of blepharospasm with toxin botulinium type A (Dysport) - as a speaker; Isfahan university of medical science-Iran 11. Nov, 1998 The 4th congress of organ transplantation: The role of transcranial Doppler(TCD) in diagnosis of brain death, oral presentation; The neurologic complications of heart and renal transplantation, poster presentation; Isfahan university of medical Science-Iran 12. May, 1999 The 21st congress of pediatric medicine and pediatric surgery: Sleep disorders in child and adolescent - as a speaker; Isfahan University of medical Science-Iran 13. Sep, 1999 The 23rd international congress of epilepsy: Lenox Gastaut syndrome- as poster presentation; Prague-Czech Republic 14. May, 2000 The 7th international congress on neurology and clinical electrophysiology: The survey of sleep disorders in 150 cases of stroke, as poster presentation; Tehran University of medical Science-Iran 15. Nov, 2000 The first congress of clinical electro neurophysiology: The study of blink reflex in multiple sclerosis; oral presentation; Tehran University of medical Science-Iran 16. Jan, 2001 The 5th meeting of the Egyptian Society of atherosclerosis: The study of prevalence of hypertension in stroke patients and control group – as poster presentation; Cairo-Egypt 17. May, 2001 The 5th international conference on preventive cardiology: The study of prevalence of diabetic mellitus in the Iranian stroke patients and control group - as poster presentation; Osaka-Japan 18. Jun, 2001 The 8th international congress on neurology and clinical electrophysiology: Drug withdrawal in patients with epilepsy: prognostic value of the EEG, as poster presentation, Tehran University of medical science-Iran 19. Sep, 2001 The 13th international congress of pediatric disease: Follow up of 106 epileptic children after discontinuation of anti-epileptic drugs - as a speaker; Tehran University of medical science-Iran 20. Sep, 2001 The first congress of medicine and judgment: Legal and Ethical aspects in vegetative states - as a speaker; Isfahan university of medical science-Iran 21. 2002 The efficacy of Lamotrigine in uncontrolled seizures- as poster presentation; Iran University of medical Sciences-Iran 22. Aug 14-16, 2002 The second congress of clinical electro neurophysiology: The study of EEG features in children and adult patients with migraine headache compared with control group – as a speaker; Tabriz University of medical Sciences-Iran 23. Jul, 2002 The 3rd conference of quality managers: as participant - Tehran -Iran 24. Aug, 2002 The second congress of psychopharmacology: The comparative study of Propranolol and Fleuxetin in prophylaxis of migraine headache – as a speaker; Isfahan University of medical Sciences-Iran 25. Oct, 2002 The 6th reform and change management in medical education: Teacher evaluation in the university hospitals- as participant; Shaheed Beheshti university of medical sciences. 26. Apr, 2003 The 10th international congress of neurology and clinical electrophysiology: A survey of prevalence of cognitive disturbances in Parkinson’s disease, oral presentation; and The study of high dose intravenous Methylprednisolone in recovery from acute MS, poster presentation - Tehran University of medical sciences, Iran 27. Jun, 2003 The 13th meeting of the European Neurological Society (ENS) , as participant -Istanbul-Turkey 28. Jun, 2004 The 14th meeting of the European Neurological Society(ENS), as participant -Barcelona-Spain 29. Jun, 2004 The 11th international congress of neurology and clinical electrophysiology: The medical Science-Iran 30. Jan, 2005 The 4th congress of psychopharmacology: The comparative study of complications of Beta interferon types in MS patients- Isfahan university of medical Science-Iran 31. Feb, 2005 The 10th Pan Arab Union of Neurological Sciences: as participant- Jeddah- Saudi Arabia 32. May, 27-31 2006 The 16th Meeting of the European Neurological Society (ENS): as Participant-Lausanne, Switzerland. 33. May, 2007 The 14th International Congress of Neurology Disorders in Iran, as speaker, Tehran, Iran. 34. Mar, 17, 2007 International Scientific Symposium” FACULTATES NOVAE MODERNARUM TRACTATIONUM” Bayer Schering Pharma, as participant, Rome Italy 35. Mar ,2007 The 8th National Congress Medical Education : The study of ideas of Interns about of their clinical education in polyclinics of Alzahra Hospital of Isfahan University. 36. Oct 11-14, 2007 The23th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 12th annual meeting of rehabilitation in MS, Prague-Czech Republic. as participant 37. Dec 4-6, 2007 The Forth Congress of Epilepsy,Tehran Iran;by Iranian Epilepsy Society; as speaker 38. May 27-30, 2008 The 15th International Congress of Neurology and Clinical Electrophysiology of Iran, Tehran, Helicobacter pylori infection and migraine: Possible role in etiology; poster presentation, The study of adverse drug reactions (ADRs) of Topiramate and Lamotrigine , poster presentation. 39. June 7-11, 2008 The 18th Meeting of the European Neurological Society(ENS): as participant- Nice, France 40. May 19-22, 2009 The 16 th Congress of Neurology & Clinical Electrophysiology of Tehran,Iran .The Frequency of Anticardiolipin, Antinuclear and Anti beta 2 glycoprotein1 Antibodies in patients with epilepsy and compare with first idiopathic seizures ; Poster presentation 41. October 26-30, 2009 The 19th World Congress of Neurology (WCN) "Innovation in Neurology" -(Bangkok-Thailand) 42. Jul 9-10, 2008 The first seminar of management of patients with supplementary and alternative medicine; Isfahan University of Medical Sciences ; as participate 43. Mar 2-4, 2009 The seminar of elderly and geriatric medicine ,Isfahan University of Medical Sciences ; as participate 44. Apr 16-17, 2009 The 1st National Congress of Stroke in Iran; Isfahan University of Medical Sciences ; Poster presentation 45. Sep 9-12, 2009 The25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis held in Düsseldorf, Germany ,as participant. 46. Oct 15-16, 2009 The 6th International Iranian Congress of Multiple Sclerosis held in Tabriz, Iran; poster presentation. 47. Oct 26-30, 2009 The 19th World Congress of Neurology (WCN) in Bangkok, Thailand, poster presentation. 48. Oct, 2009 The 6th International Congress of MS in Tabriz-Iran 49. May 27-28, 2010 The 17th International Congress of Neurology & Clinical Electrophysiology of Iran, Tehran, Iran; new antiepileptic drugs, oral presentation 50. Jun 19-23, 2010 The 20th Meeting of the European Neurological Society(ENS) Berlin, Germany; poster presentation. 51. Jul 8-9, 2010 The 2sec National Congress of Stroke in Iran; Mashhad University of Medical Sciences; as speaker 52. 4-5 Nov, 2010 The 7th International Congress of Multiple Sclerosis-(Tehran) 53. Sep, 2010 The 14th congress of EuropeanFederation -of-Neurological Societies (EFNS) -(Geneve, Swizerl) 54. Oct 13-16, 2010 The26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 15th annual meeting of rehabilitation in MS, held in Goteborg, Sweden 55. May 4-8, 2011 Serono Symposia International Foundation (SSIF) 'MS Evolving Management in the new Scenario' St.Petersburg, Russia - May 6-7, 2011, as participate 56. May 28-31, 2011, 21th Meeting of the European Neurological Society(ENS) held in Lisbon, Portugal 57. Nov, 2011 5th National Congress of Stroke, Isfahan-Iran 58. Sep13-15, 2012 The 5th Congress of the Pan-Asian Committee for treatment and Research in Multiple Sclerosis (PACTRIMS), Beijing 59. Sep8-11, 2012 The 16th Congress of the European Federation of Neurological Societies(EFNS), entitled "Alzheimer`s disease progression: advancing our standing" in Stockholm, Sweden 60. May18-19, 2012 The Serono Symposia International Foundation Conference SSIF 2012 CME Neurology Annual Meeting " MS: from disease management to patient management" Valencia, Spain 61. Oct3-5, 2012 9th Internationall Congress of Epilepsy, Tehran, Iran 62. 23-25 Oct, 2013 10th international Iranian MS congress and first congress of Devic Syndrome, Isfahan-Iran 63. 30Apr-3May 2013, 20th Congress of Neurology and Clinical Electrophysiology of Iran, Tehran-Iran 64. Feb19-21, 2014 The 1th International Congress on Challenges in Clinical Neurology in Kerman, Iran 65. January 28-30, 2015; 11th International Epilepsy Congress of Iran, Tehran, Organization by Association of epilepsy of Iran, Tehran, IRAN, as Oral Presentation: Comparison of Medications Versus Medication and Neurofeedback in Reducing Smell and Taste Disorders of patients with Refractory Left TLE. 66. 9th May 2015, 5th international congress on transcultural psychosomatic, psychiatry, and psychotherapy. Organizer: Philips university Marburg intern. Association Razi. Marburg, Germany 67. January 20-22, 2016; 12th International Epilepsy Congress of Iran, Tehran, as Poster presentation. Organization by Association of epilepsy of Iran, Tehran, IRAN, as Oral Presentation: Early and Late Posttraumatic seizures. 68. May 10-13, 2016, 23th Congress of Neurology and Clinical Electrophysiology of Iran, Tehran. Organization by Scientific Association of Neurologists of Iran (Organization code: 11570), as Poster presentation 69. 16th Nov 2016, MS and more, Zusammenfassung der kongresse ECTRIMS und DGN, Frankfurt, Germany 70. 28-31th May 2016, 2nd congress of the European academy of neurology (EAN), Copenhagen, Denmark 71. 3-4th June 2016, ISNEREM, Summer School, Spasticity-Dystonia, organized by ISNeReM and WFNR; Istanbul, Turkey 72. 28 th October 2016, 2 nd NETFORMS (Near East Forum On Multiple Sclerosis), Muscat, Oman 73. 16 Nov 2016 MS and more – Zusammenfassung der Kongress ECTRIMS und DGN, in Frankfurt. Organized by Teva GmbH . As A participant. 74. Nov 2016 Fortbildungsreihe zu Epilepsie- in Frankfurt a.M. Veranstalter: Klinik Fur Neurologie . As A participant 75. Jan 25-27, 2017, The 13th International Epilepsy Congress of Iran, Tehran, as Poster presentation: Analysis of CBZ Side effects associated with bone metabolism, Folate and Vit. B12 Serum 76. 24-25th Nov 2017, 3rd MENACTRIMS (middle east north Africa, committee for treatment and research in multiple sclerosis) congress, Dubai, UAE 77. 6 Oct 2017, 6th NETFORMS (Near East Forum On Multiple Sclerosis), Yerevan, Armenia 78. February 3-5, 2017, The 15th International Epilepsy Congress of Iran, Tehran, Presurgical evaluation: current role of invasive EEG. Oral presentation 79. 13-15 December, 2017, 14th Iran MS Congress held by Iran MS Society (Code No. 106285) at Kish Island and presenting lecture (Case Presentation) 80. 5-6 October, 2018 Neuropathy, Nutrition and Metabolism Symposium, Dubai, UAE. As A participant. 81. 24-26 Jan 2018, The 16th International Epilepsy Congress of Iran, Isfahan. Immunotherapy in treatment of Drug Resistant Epilepsy; Oral Presentation 82. 27-28 Sep 2018, EXCEMED, In-depth MRI techniques and analysis in multiple sclerosis (excellence in medical education), held in Milan, Italy, As A participant. 83. 24th-26th Jan 2018, 14th international epilepsy congress, ILAE, Isfahan, Iran 84. 13-15 Nov 2019, 16th Iranian International Congress on Multiple Sclerosis, Mashhad, IRAN; Acute combined central and peripheral demyelination A rare case report. Poster Presentation 85. 5-6th Oct 2018, neuropathy, nutrition and metabolism, Dubai, UAE 86. 10th-11th April 2019, 8th symposium on stroke, cognitive impairment and neuropathy management, organizer by Ferrer; Beirut, Lebanon; As A participant. 87- 9 July, 2019, 5 th International Congress on Psychosomatic Medicine, Challenges and Perspectives of Psycho-Oncology In Iran,(Conference and Symposium); Organized by UNIVERSITATS KLINIKUM, FRIBURG; and IUMS. As A participant. 88. 16 -18 OCTOBER 2019, The 6th Iranian International Headache Congress, Isfahan, IRAN. Sleep disorders and headache; Oral Presentation 89. 10-11 & 17-18 December 2020, 12th Iranian Stroke Congress held virtually, organized by Iranian Stroke Association. Vertebro-Basilar Dolichoectasia: A rare cause of acute ischemic stroke; Oral Presentation 90. September 11-13, 2020; MS Virtual 2020: 8th Joint ACTRIMS-ECTRIMS Meeting, Organizer by IPMA, As A participant. 91. 19 -17 February 2021, 17th International Epilepsy Congress of Iran, Tehran- Iran; SUDEP Updates. Oral Presentation 92. 2-6 Aug 2021, 28th Congress of Neurology and Clinical Electrophysiology, Tehran, Iran; Neuronal autoantibodies in focal epilepsy with or without mesial temporal sclerosis. Oral Presentation 93. 23-25 Feb 2022, The 18th International Epilepsy Congress of Iran; Advances in pharmacotherapy of sleep-related epilepsy. Oral Presentation

Research Experience :

Supervisor of Theses and Dissertations 1. The primary principles and its clinical advantages in diagnosis of MS.1993 2. Intracerebral hemorrhage and cerebral amiloidosis angiopathy confirmed by brain biopsy.1994 3. Increased intracranial pressure without papiledema.1994 4. The survey of dementing patients in Khorshid Hospital.1994 5. Grammar disturbances following right-hemispheral cerebral infarction.1994 6. The frequency of types of epilepsy in patients admitted at Isfahan University hospitals.1994 7. The frequency of clinical and paraclinical features in psychomotor seizures.1997 8. The study of vasospasm in Subarachnoid hemorrhage and the role of TCD in its early diagnosis.1997 9. The correlation between seizure relapses and predictive variables of seizures following one year discontinuation of antiepileptic drugs.1998 10. The relative frequency of diabetic mellitus in CVA patients and control group.1998 11. The relative frequency of sleep disorders in 150 CVA patients admitted in neurology ward of Al-Zahra hospital-Isfahan-Iran.1999 12. The frequency of optic neuritis in 400 MS patients.2000 13. The frequency of seizures in mental retardation children.2000 14. The comparison between Propranolol and Fleuxetin in prophylaxis of migraine headache.by Khoei ;2001 15. The relative frequency abnormal findings of blink reflex in MS patients admitted in Al-Zahra hospital-Isfahan-Iran.by M.houseininejad;2001 16. The survey of efficacy of antispasticity toxin botulinium type A, in CVA patients admitted in Al-Zahra hospital-Isfahan-Iran.by I.Rashidi,2001 17. The study of cognitive disturbances in Parkinson’s disease admitted in neurological wards-Isfahan-Iran.2001 18. The comparison of EEG findings in patients with migraine headaches and control group.2001 19. The study of efficacy high dose of Methylprednisolone during exacerbations of MS.2001 20. The study of efficacy of Lamotrigine in uncontrols epilepsy. 2002 21. The comparative study of mental health in epileptic patients with control group.2003 22. The study of opinions of stagers and interns about educational programs in the polyclinics of Alzahra hospital of Isfahan University of medical science, by E.Farzanfar; 2003 23. The comparison of monotherapy and polytherapy in the treatment of epilepsy; by E.Seidzadeh; 2003 24. The study of etiology of epileptic attacks in adult and elderly patients 2004 25. The study of biochemical bone changes of chronic Iranian epileptic patients on antiepileptic drugs (AEDS) by M.Goodarzi;2003 26. The study of adverse drug reactions (ADRs) of Topiramate and Lamotrigine in epileptic patients, by Eshaghi;2006 27. The study of effect of antiepileptic drugs on bone mineral densitometry(BMD) in chronic epileptic patients, by Mousapoor;2006 28. The study of Helicobacter pylori Infection in the migraine patients: Possible Role in Etiology; by N.Shaabani ,2006 29. The relationship of CSF IgG index and oligo clonal band with progressive course in the multiple sclerosis patients that admitted in MS clinics of Isfahan and Tehran universities between 2005-2006, by F.Najafi,Project No.20722;2006 30. The study of relative abundance distribution of restless leg syndrome in patients aged 18 and older who refer to neurology clinics of Isfahan and subjective assessment of severity of symptom ;by A.Saffarifard ,2007 31. The study of efficacy of topiramate in treatment of patients with migraine headache by questionnaires of HIT6 and MIDAS,by R.Abdi,2007 32. The Study of neuroimaging findings in epileptic patients, Isfahan ,Iran, by Z.Rezaee; Project No.:386110; 2006 33. The comparison of body mass index in two groups: tension and migraine headaches, headache clinics of Isfahan University of Medical Sciences, by N.Abedi Project No.:389024;2006 34. Evaluation of male reproduction health in epileptic patients that have been treated with antiepileptic drugs and comparison with control group, B. Ansari, Project No.388405;2007 35. Effectiveness of cognitive behavior group therapy on depression in intractable epileptic patients, Salehzadeh M,2011 36. The study of efficacy of Gabapentin in the level of consciousness of patients with head injury that admitted Kashani hospital , by Hadid Hamrah;2007 37. The survey and comparison of insulin resistance in two groups of epileptic patients treated with sodium valproate(VPA) and carbamazepine, B Ansari, Project N.:388404;2008 38. Monitoring of T helper 1 and T helper2 response in multiple sclerosis before and after immunotherapy; by H. Doulabi,2008 39. An investigation of Neuropsychological Profile of the Epileptic patients, in Comparison with Non-epileptic population; by K. Asghari;2008 40. The study of some sleep disorders (Insomnia; Sleep Apnea Syndrome; RLS) in the patients with chronic daily headache, by B. Bagheri;2008 41. Evaluation of serum vitamin B12 and it s relationship to age of onset of multiple sclerosis in Isfahan on 2008 ;project number:386419 by Maryam Mirpourian 42. The Study of Frequency of Headache in Epileptic Patients and Compare it with Control Group, by R.Khabbazian;2008 43. The assessment of serum autoantibodies in the first idiopathic generalized seizures and compare with chronic epileptic patients with antiepileptic drugs, by E.Vaziri;2008 44. Evaluation and comparison of hormonal and chemical prophiles in young adults with epilepsy taking sodium valporoate or lamotrigin Monotherapy,by G.Tayebi;2008 45. Evaluation of relative frequency of osteoporosis in muscular dystrophy patients in neuromuscular dystrophy clinics of Alzahra hospital, by Z.Nasri Nasrabadi,Project No:387015;2008 46. The study of circadian rhythms disorder and its relationship with chronic fatigue in multiple sclerosis and compare with control group, by S.Haghighi ,2009 47. A prospective controlled study of obstetric and neonatal outcome of pregnancy in women with epileps;present,Isfahan,Iran.by F.Sonbolestan, 2009 48. A controlled clinical trial study of the modified Atkins diet for intractable epilepsy in adults; by A.A Okhovat,2009 49. The survey of Edit Translate and Normalize Oral Apraxia test in ages 4 –5.11 in Isfahan,by N.Zarei Shamsabadi;2009 50. The survey of 8-Hydroxygovanozine and Testosterone in the saliva of epileptic patients and comparison with health group; M.Jabbari; Project No.:287056,2009 51. The evaluation of epidemiological characteristics in epileptic patients, Isfahan,Iran Mehdi Mirmossayeb, Mehdi Barzegar; Project number:294039 52. Determination of symptoms and risk assessment for sleep apnea syndrome in patients with acute stroke; Sarah Hosseinpoor , January 2014 53. Cognitive mechanisms underlying REBT in tension-type headache patients Chris J. Jackson(University of New South Wales, Australia)Zahra Izadikhah (The University of Southern Queensland, Australia) Zahra Mohammadi (The University of Isfahan, Iran) Mohammad Reza Najafi, 2014 54. Risk Assessment of Obstructive Sleep Apnea (OSA) and Daytime drowsiness in patients with Complex Partial Seizure (CPS), Adele Dadkhah ( Internal proposal) 2012 55. The prevalence of abnormal EEG and correlation with seizure relapse in epileptic patients and compare with control group(Internal proposal), Nafiseh Karimi, 2015 56. The study of the effectiveness of Lyubomirsky happiness training program on depression, anxiety, hope and quality of life in multiple sclerosis patients.(B.S of psychology thesis), Javad Karimi, by Dr. Nickrahan, 2015 57. Investigating of the adverse effects of antiepileptic drugs in symptomatic partial and idiopathic generalized epilepsies, in Isfahan, Fereshteh Moradi,(Internal proposal) autumn 2015 58. The survey of physiological changes in the female patients on sodium valproate and its relationship with polycystic ovarian cyst. Fatemeh Jahanshahifar,(residenty proposal) 2015 59. The survey of EEG recordings in the patients with acute stroke and compare with control group in the Al-Zahra hospital, Isfahan, Iran; Hajar Khorramdashti(residenti proposal) 2013 60. The efficacy of emotion regulation training on the psychological well-being of epileptic girls (14-18) in esfahan. Maryam Esmaeili (Degree of Doctor, psychology thesis) 2012 61. The evaluation of pituitary-hypothalamus axis hormones in patients with first tonic-clonic(grandmal) epilepsy and temporal lobe epilepsy ; Mahsa Dastjerdi, Dr. R Meamar. No: . 2014 62. Assessment of the celiac prevalence in cerebellar ataxic patients and EEG changes in Isfahan city, Mohammad Reza Najafi, Mohammad Hassan Emami, Sepideh Allahdadian, Isfahan Neurosciences Research Center, No: 195002; 2016 63. The survey of Adversive Effect of Carbamazepine on the Bone Metabolism, Serum B12 and Folate Level in epileptic patients. Mohammad Reza Najafi, Zahra Toloue-Ghamari; Isfahan Neurosciences Research Center, No: 291158; 2013 64. The survey of epidemiologic characteristics of epileptic patients referring to Al-Zahra University Hospital, Isfahan, IRAN, Mohammad Reza Najafi, Omid Mirmosayeb, Isfahan Neurosciences Research Center No: 294039: 2015 65. The study of efficacy of Neuro-Feadback on the improvement of motor weakness in the stroke patients,Karim Asgari, Mohammad Reza Najafi, Isfahan Neurosciences Research Center, No: 293283; 2015 66. The study of artifact frequencies in the EEG of patients that referring to EEG department of Al-Zahra university hospital,Isfahan Neurosciences Research Center, Mohammad Reza Najafi, Noushin Mehrbod,Nafiseh Toghianifar, Isfahan Neurosciences Research Center, No: 293007; 2014 67. The study of the effectiveness of Lyubomirsky happiness training program on depression,anxiety, hope and quality of life in multiple sclerosis patients.(General Psychology )Moradian Renani Javad(proposal for Bachlor'degree), Nickrahan Gholamreza(principal investigator), Mohammad Reza Najafi( adviser investigator) 68. The study of effectiveness of acceptance and commitment therapy on perfectionalism,emotion,regulation and copping strategies in patients with migraine Maryam Neshastehriz(proposal for Master's degree), Kouroush Namdari(principal investigator),Mohammad Reza Najafi(adviser investigator) 2016 69. The evaluation of serum levels of B12, Folate and antioxidant status in epileptic patients on treatment with Levetiracetam: A case control study Atena Mahdavi(proposal for Master'degree), Amir Mansour Alavi(principal investigator),Mohammad Reza Najafi(adviser investigator), No: 2017 70. The Effectiveness of Electromyography Biofeedback with Relaxation Training on Psychological Symptoms in Migraine Patients: Single Case Study 71. Negar Karimian Cichani( proposal for PhD.), Hamid Taher eshastdoust(principal investigator) Karim Asgari(principal investigator) Comparing various dimensions of memory in ischemic stroke patients and healthy people and investigating the effect of cognitive rehabilitation ,memory specificity training and mindfulness training on memory in patients with ischemic stroke.No: 1148005; 2014 72. The survey and evaluation of long term monitoring of gait disturbance in moderate to severe idiopathic Parkinson disease using data analysis of Rover (Sensoplex) device. Mohammad Amin Najafi, Hamid Najafi. (CEO, Sensoplex, Inc. 1735 E. Bayshore Road, suite 2B Redwood City, CA 94063+1(408)391-9019); 2018-2019 73. Title : The study of circadian rhythms disorder and its relationship with chronic fatigue in multiple sclerosis and compare with control group; Research code: 3882 75. Title : Evaluation and comparison of the effect of lacosamide with levetiracetam for control of drug resistant partial onset epilepsy in Isfahan in 1399-1400- Code : 54433 75. Evaluation of the efficacy of Methylphenidate and Modafinil in treatment of excessive daily sleepiness in patient with drug resistant epilepsy and comparison with control group; : Code : 398412 76. Comparing the effect of memantine and donepezile on improving cognitive functions in temporal lobe epilepsy in Isfahan, Iran; Code : 396530 77. Investigation on the efficacy of oral sensorimotor treatment (OST) combined with transcranial direct current stimulation (tDCS) on feeding and swallowing skills in children with cerebral palsy: A randomized, double-blind, sham-controlled, clinical trial 78. Comparative examination of the effects of melodic intonation therapy (MIT) combined with transcranial direct current stimulation (tDCS) and MIT alone on the naming ability in patients with non-fluent aphasia disorder: A randomized double-blind, controlled trial 79. Investigation on the effect of constraint-induced language therapy (CILT) combined with transcranial direct current stimulation (tDCS) in treatment of naming disorder in patients with chronic Post-Stroke non-fluent aphasia: A randomized, double-blind, sham-controlled, clinical trial 80. The effect of Fenofibrate for seizure control in refractory epilepsy patients in Isfahan in 1401-1400 81. Prevalence and characteristics of imaging, electroencephalography and laboratory tests of the first seizure related to COVID-19 and one-year follow-up of seizure outcomes – In Isfahan’s corona referral hospital (AL Zahra) Isfahan from august 2020 to February 2021 82. A rare case report of necrotizing inflammatory autoimmune myopathy following covid vaccination with Strazenka vaccine, November 24, 2021 83. A review of risk factors and brain MRI findings of stroke in patients with COVID-19 and mucor mycosis in Al-Zahra Hospital in Isfahan city during the fifth peak of corona disease between August and November 1400 and a one-month follow-up of the patients, October 14, 2021 84. A report of a family with concurrent cerebral and spinal (intramedullary) cavernous angioma and the investigation of mutations involved in this matter, and a review of related articles, November 6, 2021 85. Evaluation of the efficacy of Methylphenidate and Modafinil in treatment of excessive daily sleepiness in patient with Parkinson disease and comparison with control group, between 2021-2023 Code : 56512

Research Interests :

epilepsy

Teaching Experience :

I was very interested in education from the beginning of my studies. In 1353, I was admitted to the Faculty of Medicine of the National University of Iran (Shaheed Beheshti University). In March, 1982, I graduated with an excellent rank in the field of general medicine. After the end of my service in the Iranian Army in March, 1984, I was accepted in the field of neurology at Isfahan Medical School. In August, 1988, I won the first place in the national exams of the Iranian Board of Neurology.
1988-Present A member of Medical Faculty, Department of Neurology, Isfahan University of medical sciences, Isfahan, Iran.
Teaching various neurology topics to basic science students, externs, interns, residents and rehabilitation students. These topics are continuously taught in the form of monthly programs for each group of learners.
I am interest in the field of epilepsy, Electroencephalography (EEG), Sleep disorder and polysomnography

Teaching Interests :

Class title or subject
For Students
1- Dementia & Delirium
2- Vertigo & Dizziness
3- Neurologic Examinations
For Neurology Residents
1- A Course of Sleep Disorders and Polysomnography
2- A course of Clinical Examinations includes Patient Management Problems, Key Features Problems, OSCE and etc.